PLEASANTON, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will hold a conference call on Monday, October 27, to discuss Friday's announcement regarding its HeartMate II.
The call will take place at 5:30 a.m., Pacific Daylight Time, (8:30 a.m., Eastern Daylight Time), and can be accessed by calling (785) 830-7991, passcode 8900544. The webcast will be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=95989&eventID=2008026, or on the company's website at http://www.thoratec.com/.
A replay of the conference call will be available through November 3, via http://www.thoratec.com/ or by telephone at (719) 457-0820, passcode 8900544.
Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate II LVAS (Left Ventricular Assist System) with nearly 12,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com/ or http://www.itcmed.com/.
